Questions Remain Over Synlait's Advanced Nutrition -- Market Talk

Dow Jones
16小时前

2323 GMT - Synlait Milk's turnaround has been quicker than Bell Potter analyst Jonathan Snape anticipated, but question marks remain over the future of the dairy producer's advanced nutrition business. Snape tells clients that the pace of the turnaround has been reflected by a rally in Synlait's shares. He calls out the improvement in Synlait's ingredients business, continued cost control, and new business development within advanced nutrition. However, he warns that the latter could take a hit if a2 Milk, which had an exclusivity agreement with Synlait until January 2025, vertically integrates into supply chain assets. Bell Potter raises its target price to A$0.90 from A$0.425, and maintains a hold rating. Shares are up 2.5% at A$0.83. (stuart.condie@wsj.com)

 

(END) Dow Jones Newswires

March 09, 2025 19:23 ET (23:23 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10